Zweijährliche Tagung zum Europäischen Pharmarecht 2010
|
, 15. April 2010 – 16. April 2010 |
|
|
Sprache: |
|
|---|---|
|
Tagungsnummer: |
210R02 |
 |
|
|
Rechtsgebiete: |
Geistiges Eigentum |
|---|
This conference will offer an overview of the latest innovations in
European legislative activity and the most important recent case law
and pending judgments of the Court of Justice of the European Union
(CJEU) affecting the pharmaceutical sector:
Pharmaceutical law and competition law
Pharmaceutical law and competition law
- Pending CJEU rulings on Article 101 TFEU such as GSK (C-501/06) and on Article 102 such as AstraZeneca (T-321/05) and pending cases before the European Commission
- The way forward the pharmaceutical sector inquiry
- Follow-up of the legislative proposal on counterfeiting of medicines (COM(2008)668)
- Pharmaceutical patent litigation settlements, patent linkage, licensing agreements
- Follow-up to the proposal for a unified patent litigation system
- New projects in the pipeline, including the current discussions on the clinical trial directive, follow-up of the 2008 pharmaceutical legislative package
- Emerging new technologies and legal status of borderline products
Newsletter
Programm
Wichtiger Hinweis
Ihre Teilnahme an dieser Tagung ist ein wichtiger Beitrag zu Ihrer beruflichen Fortbildung.
Datenschutzerklärung
Allgemeine Geschäftsbedingungen
Impressum
Hinweisgebersystem der Europäischen Rechtsakademie Trier (ERA)
Allgemeine Geschäftsbedingungen
Impressum
Hinweisgebersystem der Europäischen Rechtsakademie Trier (ERA)
